Therapy Areas: Oncology
Kura Oncology reports early activity for darlifarnib–cabozantinib combination in cabozantinib‑pretreated ccRCC
...
Newbury Pharmaceuticals secures first Scandinavian approval for palbociclib generic
17 April 2026 - Swedish pharmaceutical company Newbury Pharmaceuticals AB (STO:NEWBRY) announced on Friday that it has obtained Marketing Authorization in Denmark for Palbociclib Newbury tablets, mark...
Bold Therapeutics reports protection against chemotherapy-induced peripheral neuropathy with BOLD-100 anticancer agent
17 April 2026 - Canadian clinical-stage biopharmaceutical company Bold Therapeutics Inc on Thursday released new data highlighting the ability of its lead asset, BOLD-100, to demonstrate protective ef...
Philips secures FDA clearance for Spectral CT Verida system
...
Circio partners with Acuitas to evaluate in vivo CAR-T cell therapy technology
15 April 2026 - Biotechnology company Circio Holding ASA (OSE:CRNA) announced on Wednesday that it has entered into an evaluation agreement with Canadian biotechnology company Acuitas Therapeutics to ...
Poolbeg Pharma secures MHRA approval for POLB 001 trial as US research highlights multi-billion dollar potential
15 April 2026 - Biopharmaceutical company Poolbeg Pharma plc (AIM: POLB) announced on Wednesday that it has received Clinical Trial Authorisation from the UK Medicines and Healthcare products Regulato...